V. To determine the cumulative incidence and severity of chronic GvHD. VI. To determine the cumulative incidence of grades III-IV acute GvHD. VII. To evaluate health related quality of life. VIII. To determine donor and recipient chimerism. IX. To evaluate immune reconstitution.